首頁資訊直腸癌患者術后排尿功能障礙的危險因素研究進展

直腸癌患者術后排尿功能障礙的危險因素研究進展

來源：泰然健康網(wǎng) 時間：2024年12月22日 21:05

排尿功能障礙是直腸癌患者術后生存質(zhì)量下降的重要因素之一，排尿功能障礙的類型及程度受多種因素影響，包括患者相關因素，如年齡、性別、腫瘤相關因素等；治療相關因素，如手術術式、是否輔助放化療等?，F(xiàn)有研究從不同角度闡述了直腸癌患者術后排尿功能障礙發(fā)生的危險因素。本文通過回顧近年來關于直腸癌的手術治療及術后生活質(zhì)量研究的文獻，總結患者相關因素和治療相關因素對直腸癌患者術后排尿功能障礙的影響，以期全面闡明直腸癌術后患者排尿功能障礙可能存在的危險因素，有助于改進治療措施來降低患者術后排尿功能障礙的發(fā)生率。

Micturition dysfunction is one of the important factors for the decline of postoperative quality of life in patients with rectal cancer. The type and degree of micturition dysfunction are affected by many factors, including patient related factors, such as age, gender, tumor related factors and treatment related factors, such as surgical procedure, whether adjuvant radiotherapy and chemotherapy or not, etc. Existing studies have expounded the risk factors of postoperative micturition dysfunction in patients with rectal cancer from different angles. By reviewing the literature on the surgical treatment and postoperative quality of life of rectal cancer in recent years, this paper summarizes the effects of patient related factors and treatment related factors on postoperative micturition dysfunction in patients with rectal cancer. In order to comprehensively clarify the possible risk factors of postoperative micturition dysfunction in patients with rectal cancer, it is helpful to improve treatment measures to reduce the incidence of postoperative urinary dysfunction.

[1] Wani RA

Bhat IU

Parray FQ

, et al. Quality of life after "Total Mesorectal Excision (TME)" for rectal carcinoma: a study from a Tertiary Care Hospital in Northern India[J]. Indian J Surg Oncol, 2017, 8(4): 499-505.

[2] Veltcamp Helbach M

Koedam TWA

Knol JJ

, et al. Quality of life after rectal cancer surgery: differences between laparoscopic and transanal total mesorectal excision[J]. Surg Endosc, 2019, 33(1): 79-87.

[3] Karlsson L

Bock D

Asplund D

, et al. Urinary dysfunction in patients with rectal cancer: a prospective cohort study[J]. Colorectal Dis, 2020, 22(1): 18-28.

[4] Dulskas A

Samalavicius NE

. A prospective study of sexual and urinary function before and after total mesorectal excision[J]. Int J Colorectal Dis, 2016, 31(6): 1125-1130.

[5] Abdelli A

Tillou X

Alves A

, et al. Genito-urinary sequelae after carcinological rectal resection: What to tell patients in 2017[J].J Visc Surg, 2017, 154(2): 93-104.

[6] Beraldo FB

Yusuf SA

Palma RT

, et al. Urinary dysfunction after surgical treatment for rectal cancer[J]. Arq Gastroenterol, 2015, 52(3): 180-185.

[7] Cheung F

Sandhu JS

. Voiding dysfunction after non-urologic pelvic surgery[J]. Curr Urol Rep, 2018, 19(9): 75.

[8] Ito M

Kobayashi A

Fujita S

, et al. Urinary dysfunction after rectal cancer surgery: Results from a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for clinical stage II or III lower rectal cancer (Japan Clinical Oncology Group Study, JCOG0212) [J]. Eur J Surg Oncol, 2018, 44(4): 463-468.

[9] Hamamoto H

Yamamoto M

Masubuchi S

, et al. Male sex and anterior wall tumor location as risk factors for urinary dysfunction after laparoscopic rectal surgery[J]. Surg Endosc, 2020, 34(8): 3567-3573.

[10] Duran E

Tanriseven M

Ersoz N

, et al. Urinary and sexual dysfunction rates and risk factors following rectal cancer surgery[J]. Int J Colorectal Dis, 2015, 30(11): 1547-1555.

[11] Fernandez-Martinez D

Rodriguez-Infante A

Otero-Diez JL

, et al. Is my life going to change?-a review of quality of life after rectal resection[J]. J Gastrointest Oncol, 2020, 11(1): 91-101.

[12] Doeksen A

Gooszen JA

van Duijvendijk P

, et al. Sexual and urinary functioning after rectal surgery: a prospective comparative study with a median follow-up of 8.5 years[J]. Int J Colorectal Dis, 2011, 26(12): 1549-1557.

[13] Pocard M

Zinzindohoue F

Haab F

, et al. A prospective study of sexual and urinary function before and after total mesorectal excision with autonomic nerve preservation for rectal cancer[J]. Surgery, 2002, 131(4): 368-372.

[14] Uebersax JS

Wyman JF

Shumaker SA

, et al. Short forms to assess life quality and symptom distress for urinary incontinence in women: the incontinence impact questionnaire and the urogenital distress inventory. continence program for women research group[J].Neurourol Urodyn, 1995, 14(2): 131-139.

[15] Hur H

Bae SU

Kim NK

, et al. Comparative study of voiding and male sexual function following open and laparoscopic total mesorectal excision in patients with rectal cancer[J]. J Surg Oncol, 2013, 108(8): 572-578.

[16] Yamaoka Y

Kagawa H

Shiomi A

, et al. Robotic-assisted surgery may be a useful approach to protect urinary function in the modern era of diverse surgical approaches for rectal cancer[J]. Surg Endosc, 2021, 35(3): 1317-1323.

[17] Lange MM

van de Velde CJ

. Urinary and sexual dysfunction after rectal cancer treatment[J]. Nat Rev Urol, 2011, 8(1): 51-57.

[18] Ledebo A

Bock D

Prytz M

, et al. Urogenital function 3 years after abdominoperineal excision for rectal cancer[J]. Colorectal Dis, 2018, 20(6): O123-O134.

[19] Kwaan MR

Fan Y

Jarosek S

, et al. Long-term risk of urinary adverse events in curatively treated patients with rectal cancer: a population-based analysis[J]. Dis Colon Rectum, 2017, 60(7): 682-690.

[20] Sartori CA

Sartori A

Vigna S

, et al. Urinary and sexual disorders after laparoscopic TME for rectal cancer in males[J]. J Gastrointest Surg, 2011, 15(4): 637-643.

[21] McGlone ER

Khan O

Flashman K

, et al. Urogenital function following laparoscopic and open rectal cancer resection: a comparative study[J]. Surg Endosc, 2012, 26(9): 2559-2565.

[22] Zhao Y

Hou XL

Ding JH

, et al. Early urinary dysfunction after laparoscopic rectal cancer surgery: does surgeons' learning curve matter? [J]. Am Surg, 2018, 84(5): 658-666.

[23] Qiao Q

Che X

Li X

, et al. Recovery of urinary functions after laparoscopic total mesorectal excision for T4 rectal cancer[J]. J Laparoendosc Adv Surg Tech A, 2016, 26(8): 614-617.

[24] Shiraishi T

Ito M

Sasaki T

, et al. Association between urinary function and resected pattern of the autonomic nerve system after transanal total mesorectal excision for rectal cancer[J]. Colorectal Dis, 2021, 23(2): 405-414.

[25] Ma B

Gao P

Song Y

, et al. Transanal total mesorectal excision (taTME) for rectal cancer: a systematic review and meta-analysis of oncological and perioperative outcomes compared with laparoscopic total mesorectal excision[J]. BMC Cancer, 2016, 16: 380.

[26] Kowalewski KF

Seifert L

Ali S

, et al. Functional outcomes after laparoscopic versus robotic-assisted rectal resection: a systematic review and meta-analysis[J]. Surg Endosc, 2021, 35(1): 81-95.

[27] Yamaguchi T

Kinugasa Y

Shiomi A

, et al. Robotic-assisted vs. conventional laparoscopic surgery for rectal cancer: short-term outcomes at a single center[J]. Surg Today, 2016, 46(8): 957-962.

[28] Wee IJY

Kuo LJ

Ngu JC

. Urological and sexual function after robotic and laparoscopic surgery for rectal cancer: A systematic review, meta-analysis and meta-regression[J]. Int J Med Robot, 2021, 17(1): 1-8.

[29] Kim HJ

Choi GS

Park JS

, et al. The impact of robotic surgery on quality of life, urinary and sexual function following total mesorectal excision for rectal cancer: a propensity score-matched analysis with laparoscopic surgery[J]. Colorectal Dis, 2018, 20(5): O103-O113.

[30] Oshio H

Oshima Y

Yunome G

, et al. Potential urinary function benefits of initial robotic surgery for rectal cancer in the introductory phase[J]. J Robot Surg, 2022, 16(1): 159-168.

[31] Wang G

Wang Z

Jiang Z

, et al. Male urinary and sexual function after robotic pelvic autonomic nerve-preserving surgery for rectal cancer[J].Int J Med Robot, 2017, 13(1): e1725.

[32] Morelli L

Ceccarelli C

Di Franco G

, et al. Sexual and urinary functions after robot-assisted versus pure laparoscopic total mesorectal excision for rectal cancer[J]. Int J Colorectal Dis, 2016, 31(4): 913-915.

[33] Kim JY

Kim NK

Lee KY

, et al. A comparative study of voiding and sexual function after total mesorectal excision with autonomic nerve preservation for rectal cancer: laparoscopic versus robotic surgery[J]. Ann Surg Oncol, 2012, 19(8): 2485-2493.

[34] Luca F

Valvo M

Ghezzi TL

, et al. Impact of robotic surgery on sexual and urinary functions after fully robotic nerve-sparing total mesorectal excision for rectal cancer[J]. Ann Surg, 2013, 257(4): 672-678.

[35] Wang X

Qiu A

Liu X

, et al. Total mesorectal excision plus lateral lymph node dissection vs TME on rectal cancer patients: a meta-analysis[J]. Int J Colorectal Dis, 2020, 35(6): 997-1006.

[36] Hirata Y

Nozawa H

Kawai K

, et al. The influence of neoadjuvant chemoradiation for lower rectal cancer on urinary function[J].Asian J Surg, 2019, 42(7): 731-739.

[37] Huang M

Lin J

Yu X

, et al. Erectile and urinary function in men with rectal cancer treated by neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy alone: a randomized trial report[J]. Int J Colorectal Dis, 2016, 31(7): 1349-1357.

[38] Toritani K

Watanabe J

Suwa Y

, et al. The risk factors for urinary dysfunction after autonomic nerve-preserving rectal cancer surgery: a multicenter retrospective study at Yokohama Clinical Oncology Group (YCOG1307) [J]. Int J Colorectal Dis, 2019, 34(10): 1697-1703.

[39] Lee SY

Kang SB

Kim DW

, et al. Risk factors and preventive measures for acute urinary retention after rectal cancer surgery[J].World J Surg, 2015, 39(1): 275-282.

[1]劉歡顏, 華揚, 賈凌云, 趙新宇, 劉蓓蓓. 頸內(nèi)動脈閉塞病變管腔結構和血流動力學特征分析[J]. 中華醫(yī)學超聲雜志（電子版）, 2023, 20(08): 809-815.[2]馬艷波, 華揚, 劉桂梅, 孟秀峰, 崔立平. 中青年人頸動脈粥樣硬化病變的相關危險因素分析[J]. 中華醫(yī)學超聲雜志（電子版）, 2023, 20(08): 822-826.[3]陳旭淵, 羅仕云, 李文忠, 李毅. 腺源性肛瘺經(jīng)手術治療后創(chuàng)面愈合困難的危險因素分析[J]. 中華普外科手術學雜志(電子版), 2024, 18(01): 82-85.[4]唐旭, 韓冰, 劉威, 陳茹星. 結直腸癌根治術后隱匿性肝轉移危險因素分析及預測模型構建[J]. 中華普外科手術學雜志(電子版), 2024, 18(01): 16-20.[5]張生軍, 趙阿靜, 李守博, 郝祥宏, 劉敏麗. 高糖通過HGF/c-met通路促進結直腸癌侵襲和遷移的實驗研究[J]. 中華普外科手術學雜志(電子版), 2024, 18(01): 21-24.[6]張焱輝, 張蛟, 朱志賢. 留置肛管在中低位直腸癌新輔助放化療后腹腔鏡TME術中的臨床研究[J]. 中華普外科手術學雜志(電子版), 2024, 18(01): 25-28.[7]吳方園, 孫霞, 林昌鋒, 張震生. HBV相關肝硬化合并急性上消化道出血的危險因素分析[J]. 中華普外科手術學雜志(電子版), 2024, 18(01): 45-47.[8]關旭, 王錫山. 基于外科與免疫視角思考結直腸癌區(qū)域淋巴結處理的功與過[J]. 中華結直腸疾病電子雜志, 2023, 12(06): 448-452.[9]顧睿祈, 方洪生, 蔡國響. 循環(huán)腫瘤DNA檢測在結直腸癌診治中的應用與進展[J]. 中華結直腸疾病電子雜志, 2023, 12(06): 453-459.[10]陸猛桂, 黃斌, 李秋林, 何媛梅. 蜂蟄傷患者發(fā)生多器官功能障礙綜合征的危險因素分析[J]. 中華臨床醫(yī)師雜志(電子版), 2023, 17(9): 1010-1015.[11]李達, 張大涯, 陳潤祥, 張曉冬, 黃士美, 陳晨, 曾凡, 陳世鋦, 白飛虎. 海南省東方市幽門螺桿菌感染現(xiàn)狀的調(diào)查與相關危險因素分析[J]. 中華臨床醫(yī)師雜志(電子版), 2023, 17(08): 858-864.[12]李琪, 黃鐘瑩, 袁平, 關振鵬. 基于某三級醫(yī)院的ICU多重耐藥菌醫(yī)院感染影響因素的分析[J]. 中華臨床醫(yī)師雜志(電子版), 2023, 17(07): 777-782.[13]孟科, 李燕, 閆婧爽, 閆斌. 膠囊內(nèi)鏡胃通過時間的影響因素分析[J]. 中華臨床醫(yī)師雜志(電子版), 2023, 17(06): 671-675.[14]楊艷麗, 陳昱, 趙若辰, 杜偉, 馬海娟, 許珂, 張莉蕓. 系統(tǒng)性紅斑狼瘡合并血流感染的危險因素及細菌學分析[J]. 中華臨床醫(yī)師雜志(電子版), 2023, 17(06): 694-699.[15]孫培培, 張二明, 時延偉, 趙春燕, 宋萍萍, 張碩, 張克, 周玉嬌, 趙璨, 閆維, 吳蓉菊, 宋麗萍, 郭偉安, 馬石頭, 安欣華, 包曹歆, 向平超. 北京市石景山區(qū)40歲及以上居民慢性阻塞性肺疾病患病情況及相關危險因素分析[J]. 中華臨床醫(yī)師雜志(電子版), 2023, 17(06): 711-719.閱讀次數(shù)全文